A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia

BMJ Open 2017; 7: e016701.
Authors: Fabbri A, Grundy Q, Mintzes B, et al
“To analyse patterns and characteristics of pharmaceutical industry sponsorship of events for Australian health professionals and to understand the implications of recent changes in transparency provisions that no longer require reporting of payments for food and beverages.”
Find article here.

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement

JAMA. 2017; 317(24): 2479-2480.
Authors: Sham Mailankody, Vinay Prasad
“This Viewpoint uses the recent instance of disease awareness promotion on a television soap opera to discuss questions about the role and regulation of novel forms of direct-to-consumer disease awareness marketing.”
Find article here.

A doctor prescribed so many painkillers, she’s been charged with murdering her patients, authorities say

Washington Post, 24 June 2017
Author: Cleve R. Wootson Jr.
“Law enforcement agents aren’t just going after drug dealers and Mexican cartels — they’re also targeting pharmaceutical companies and doctors, who they say are irresponsibly flooding the nation with potent painkillers, and holding them responsible for overdose deaths.”
Find article here.

AbbVie must pay $15 million in Depakote birth-defect trial: jury

Reuters, 9 June 2017
Author: Nate Raymond
“A federal jury on Friday awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc’s (ABBV.N) bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds of lawsuits over the product.”
Find article here.

 

Are Pharmaceutical Companies to Blame for the Opioid Epidemic?

The Atlantic, 2 June 2017
Author: Alana Semuels
“Who is responsible for this? Some attorneys general and advocates are now asking in court whether the pharmaceutical companies who marketed the drugs and downplayed their addictive nature can be held legally responsible for – and made to pay for the consequences of – the crisis.”
Find article here.

Ohio Sues 5 Major Drug Companies For ‘Fueling Opioid Epidemic’

NPR, 31 May 2017
Author: Colin Dwyer
“The state of Ohio has sued five major drug manufacturers for their role in the opioid epidemic. In the lawsuit filed Wednesday, state Attorney General Mike DeWine alleges these five companies “helped unleash a health care crisis that has had far-reaching financial, social, and deadly consequences in the State of Ohio.”
Find article here.

Modernizing And Strengthening Existing Laws To Control Drug Costs

Health Affairs Blog, 31 March 2017
Authors: Tim Horn, Sean Dickson
“If President Trump truly intends to control drug costs, we offer four proposals that leverage existing drug pricing systems to reduce prices for both public and private payers; in this Blog post, we will describe two of the proposals in depth.”
Find article here.

EU recommends suspending hundreds of drugs tested by Indian firm

Reuters, 25 March 2017
Author: Ben Hirschler
“Europe’s medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to “unreliable” tests conducted by Indian contract research firm Micro Therapeutic Research Labs.”
Find article here.